These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 475375)

  • 1. Human fibroblast interferon for clinical trials: pharmacokinetics and tolerability in experimental animals and humans.
    Billiau A; De Somers P; Edy VG; De Clercq E; Heremans H
    Antimicrob Agents Chemother; 1979 Jul; 16(1):56-63. PubMed ID: 475375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of vaccinia lesions in Rhesus monkeys by human leucocyte and fibroblast interferon.
    Weimar W; Stitz L; Billiau A; Cantell K; Schellekens H
    J Gen Virol; 1980 May; 48(1):25-30. PubMed ID: 6155433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Side effects of long-term treatment with human leukocyte interferon.
    Ingimarsson S; Cantell K; Strander H
    J Infect Dis; 1979 Oct; 140(4):560-3. PubMed ID: 292735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of rates of clearance of human fibroblast and leukocyte interferon from the circulatory system of rabbits.
    Edy VG; Billiau A; De Somer P
    J Infect Dis; 1976 Jun; 133 Suppl():A18-21. PubMed ID: 932502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interferons--its method of administration and adverse effect related to pharmacokinetics ].
    Furue H
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):186-93. PubMed ID: 6582804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerability of pure fibroblast interferon in man.
    Billiau A; Heine JW; Van Damme J; Heremans H; De Somer P
    Ann N Y Acad Sci; 1980; 350():374-5. PubMed ID: 6165288
    [No Abstract]   [Full Text] [Related]  

  • 7. Tissue distribution of human interferons after exogenous administration in rabbits, monkeys, and mice.
    Billiau A; Heremans H; Ververken D; van Damme J; Carton H; de Somer P
    Arch Virol; 1981; 68(1):19-25. PubMed ID: 6166278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human fibroblast interferon for clinical trials: production, partial purification, and characterization.
    Billiau A; Damme JV; Leuven FV; Edy VG; De Ley M; Cassiman JJ; Van de Berghe H; De Somer P
    Antimicrob Agents Chemother; 1979 Jul; 16(1):49-55. PubMed ID: 475374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purified human fibroblast interferon in vivo: skin reactions and effect on bone marrow precursor cells.
    Carter WA; Dolen JG; Leong SS; Horoszewicz JS; Vladutiu AO; Leibowitz AI; Nolan JP
    Cancer Lett; 1979 Sep; 7(5):243-9. PubMed ID: 509407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of the safety, reactogenicity, and allergenicity of swine leukocyte interferon in experiments on animals and observations of volunteers].
    Solov'ev VD; Marchenko VI; Pozhidaev IuI; Zubanova NA; Volodina TN
    Vopr Virusol; 1981; (1):12-7. PubMed ID: 6167066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and laboratory investigations on man: systemic administration of potent interferon to man.
    Strander H; Cantell K; Carlström G; Jakobsson PA
    J Natl Cancer Inst; 1973 Sep; 51(3):733-42. PubMed ID: 4355215
    [No Abstract]   [Full Text] [Related]  

  • 12. Interferon: pharmacokinetics and toxicity.
    Scott GM
    Philos Trans R Soc Lond B Biol Sci; 1982 Sep; 299(1094):91-107. PubMed ID: 6183699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial interaction of human fibroblast and leukocyte interferons with FS-4 fibroblasts.
    Gardner LJ; Vilcek J
    J Gen Virol; 1979 Jul; 44(1):161-8. PubMed ID: 227987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Distribution of human interferon in organs and tissues after its administration to man and animals].
    Maiakova SA; Berulava II; Gavrilova IE; Kuznetsov VP
    Vopr Virusol; 1980; (5):594-6. PubMed ID: 6159738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of administered interferon on rabies in rabbits.
    Postic B; Fenje P
    Appl Microbiol; 1971 Sep; 22(3):428-31. PubMed ID: 4330317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of human recombinant interferon-beta in monkeys and rabbits.
    Gomi K; Morimoto M; Inoue A; Kobayashi H; Deguchi T; Hara T; Nakamizo N
    Gan; 1984 Mar; 75(3):292-300. PubMed ID: 6724230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of human leukocyte interferon.
    Cantell K; Pyhälä L
    J Infect Dis; 1976 Jun; 133 Suppl():A6-12. PubMed ID: 932506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of leukocyte and fibroblast interferon on events in the fibroblast cell cycle.
    Lundgren E; Larsson I; Miörner H; Strannegård O
    J Gen Virol; 1979 Mar; 42(3):589-95. PubMed ID: 430031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible causes of fever after interferon administration.
    Bocci VU
    Biomedicine; 1980 Dec; 32(4):159-62. PubMed ID: 6162489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon skin reactivity and pyrexial reactions.
    Scott GM; Butler JK; Cartwright T; Richards BM; Kingham JG; Wright R; Tyrrell DA
    Lancet; 1977 Aug; 2(8034):402-3. PubMed ID: 70611
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.